We have clinically evaluated the Dade 'Cardiozyme" immunoinhibition procedure for determination of creatine kinaSe isoenzyme MB (CK-MB) in 71 patients who were suspected of having had an acute myocardial infarction. Electrophoresis for CK-MB was also carried out. On the basis of diagnostic sensitivity and specificity for myocardial infarction, we found the Dade procedure for CK-MB to be somewhat inferior to electrophoresis.
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In 11 patients for whom the time of infarction was known, we observed normal CK-MB results for two of them by both immunoinhibition and electrophoresis during the first 24 h, but subsequently could detect abnormal CK-MB results by both methods. Thus in some patients such data are not helpful for making a diagnosis in the first 24 h. The Dade procedure is easy to perform, but lacks sensitivity in the region of low CK-MB activity, requires a very stable spectrophotometer, is imprecise, and produces negative numerical results in patients without myocardial infarction.
The correct diagnosis of acute myocardial infarction is of paramount importance, because its misdiagnosis can result in a fatal outcome for the patient. Any new diagnostic procedure for it must be at least as good or better than an existing procedure for it to be clinically appropriate.
Abnormal serum enzyme activities-in particular AST, CK, LD, and the isoenzymes of CK and LD-have become extremely valuable in the diagnosis of acute myocardial infarction in patients with suspicious clinical signs.2 This area of diagnostic enzymology has been reviewed in some detail (1) (2) (3) . Creatine kinase MB isoenzyme (CK-MB) is the most sensitive and specific for acute myocardial infarction of all the commonly done enzyme tests. The average sensitivity and specificity of CK-MB are 98 and 98%, as calculated from data in seven recent reports in which CK-MB was determined electrophoretically (4) (5) (6) (7) (8) (9) (10) , and 99 and 95%, respectively, where CK-MB was determined chromatographically (11, 12) . All of the other enzyme tests-AST, CK, LD, or LD isoenzymes-had average sensitivities and specificities that were less than that of CK-MB for acute myocardial infarction in the above reports. An immunoinhibition method for CK-MB (13) had a sensitivity of 70% and specificity of 95% and therefore was somewhat inferior to the other methods.
The procedure most widely used for CK-MB is electrophoresis (4) (5) (6) (7) (8) (9) (10) (11) (12) (18) , and 8% of the time by us (July 1979, 11 of 136 samples had distinct or trace CK-BB band). Further, the CK-BB band is usually faint and represents only a small part of the total CK activity. Thus the error introduced by also measuring CK-BB is negligible in most patients.
We wanted to evaluate the Dade method for possible use in our laboratory. Clearly, a laboratory comparison with electrophoresis is not enough, because it is the diagnostic sensitivity and specificity of any new procedure for acute myocardial infarction that determines its value. Therefore we did a clinical study of the Dade procedure for patients admitted to our cardiac intensive-care unit.
Materials and Methods

Patient
group. Seventy-five patients admitted to the coronary care unit during a six-month period were included in the study. The patients were selected without conscious bias from among those admitted to the unit during this time. All the patients we chose had requests for enzyme and isoenzyme studies. Four patients were excluded from further analysis because the samples were hemolyzed, because of incomplete isoenzyme data, or because the patient died before diagnosis. The 71 patients were all studied for at least two days at 12-h intervals after admission; 55 of the patients were studied for three or more days. CK determinations were performed within 24 h of receipt of samples and the isoenzyme studies were performed within 48 h of receipt. The diagnoses were obtained from the discharge summary of each of the patients. The diagnoses of acute myocardial infarction or no acute myocardial infarction were made on the basis of clinical or electrocardiographic findings, CK and LD isoenzymes by electrophoresis, assays for total CK and AST, and technetium scans for some of the patients.
The Dade results were not available to the clinicians in making their diagnoses. For LD isoenzymes, we never saw LD1 greater than LD2 in 50 blood donors with non-hemolyzed blood. For the Dade procedure, we used Dade's value of less than 4 UIL for CK-MB. A patient was considered to have an abnormal result if any value obtained within the first 48 h after admission to the unit was above the normal range.
Results and Discussion
Patient findings. Of the 71 patients, 28 were diagnosed as having suffered an acute myocardial infarction.
Our results are summarized in Table 1 . Determination of CK-MB is clearly an excellent test to differentiate acute myocardial infarction from no infarction, and the electrophoretic procedure is somewhat superior to the immunoinhibition procedure.
Nevertheless,
the Dade method appears to provide useful clinical information. It is somewhat unfair to compare the electrophoretic procedure to the Dade method for CK-MB, because the clinicians saw the former but not the latter in making their diagnoses. One patient with pericarditis and myocarditis, but not acute myocardial infarction, had abnormal results for all four tests (Table 1) . Were he removed from the group in Table 1 , the specificity of all the tests would improve. It is well known that CK often gives falsely positive results, usually an effect of intramuscular injections. The four cases with acute myocardial infarction where the Dade results were falsely negative all had 4 or fewer Sigma units of CK-MB, i.e., the Dade kit may lack some sensitivity in the low activity range. However, seven patients of 23, all with acute myocardial infarction and with four or fewer Sigma Temporal sensitivity of enzyme tests. We attempted to determine the optimum interval after infarction for measuring serum enzymes most usefully. We were able to obtain a good estimate of the time of infarction in 11 patients ( and the reagents for the Rosalki reaction. The absorbance change per minute is followed after a 7-mm incubation. The reagent contains reduced glutathione (GSH) as an activator. As Klotzsch has pointed out (19) , glutathione reductase (NAD(P)H) (BC 1.6.4.2) catalyzes the reaction: GSSG + NAD(P)H + H 2 GSH + NAD(P). Reduced glutathione always contains some oxidized glutathione, because oxidized glutathione forms during lyophilization of reduced glutathione. In the presence of glutathione reductase, which normally appears in blood, the above reaction consumes NAD(P)H and could lead to a negative absorbance change with time. The net absorbance change seen in the Dade procedure may be the result of competing reactions to produce and consume NAD(P)H.
This may be why, in the presence of small amounts of CK-MB, the Dade procedure gives false-negative results and why negative numerical results are seen with non-infarct patients. We wanted to test the effect of dilution on the observed activity in view of Morin's observations (20) that the Dade method gives nonlinear dilutions. For an undiluted sample with 17 U/L CK-MB we observed 9 and 7 U/L for a twofold dilution (with isotonic saline), 8, 5, and 5 U/L for a three-fold dilution, and 0 and 4 U/L on a sixfold dilution. The analytical recoveries were imprecise and inaccurate at the higher dilutions.
Quality control results. One operator analyzed in replicate the Dade Cardiozyme controls I and II by the Dade method, with the following results: for I, 6.6 ± 2.5 U/L (SD), n = 28; for II, 27.9 ± 5.6 U/L (SD), n = 37. Control results for electrophoresis for Sigma "CPK Isotrol" done at this time by a variety of operators were: CK-MM, 41.9 ± 3.7% (SD); CK-MB, 35.1 ± 2.3% (SD), and CK-BB, 22.9 ± 3.0% (SD), n = 36.
We conclude that electrophoresis is the better clinical method for CK-MB of the two methods compared here. The Dade method is clearly easier to use in the laboratory and could be automated on a precision spectrophotometer, but it appears to have difficulty detecting low proportions of CK-MB. There may be an interference from oxidized glutathione which could produce the negative numerical results for CK-MB that we observed in samples from patients without acute myocardial infarction. Very stable spectrophotometry is necessary with the Dade method, because a drift of only 0.001 A per 5 mm in the decision region between normal and abnormal is intolerable; possibly for this reason our precision with the method and our recovery of diluted samples was poor.
